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The increasing use of smartphones and technological advan-
ces has given rise to a range of applications for medical and 
healthcare purposes. The field of oncology is no exception, 
with applications being made available for, amongst others, 
education, treatment information, prevention and early de-
tection [1]. A large proportion of the applications claiming to 
provide the opportunity for early detection are active within 
the field of skin cancer.
Several types of apps are available in the area of skin cancer. 
Some apps provide general information about melanoma, 
others provide information about prevention and a number 
of apps provide an estimate of the risk whether a certain lesion 
is malignant based on a picture taken [2]. A systematic review 
conducted in 2018 showed that the accuracy of the latter type 
of app was not sufficient at that time [3]. The evidence was also 
rather limited in quality and quantity. This was confirmed by 
a very recent systematic review [4] which showed that apps 
currently are unable to identify all skin cancers. In this case, the 
studies were also of limited methodological quality and had 
relatively small sample sizes. In another review [5], the sensiti-
vity ranged from 7% to 87%. Another problem that was often 
mentioned, is the high rate of unusable images taken [2, 3, 5].
Due to the variation in accuracy between apps, it is im-
portant that every app intended for medical use is individu-
ally tested for accuracy. This could be set as a requirement 
for regulatory approval. Currently this is not always the case 
when applying for a CE-mark. An example of an application 
that is aiming to become part of medical care is SkinVision 
(SkinVision, Amsterdam) In the Benelux, it seems that this app 
has gone the furthest in the direction of regulatory approval.
It is included in the Belgian mHealth validation pyramid and 
has received a CE-mark as a class I medical device. It is addi-
tionally cooperating with a Dutch health insurer. However, the 
app has also attracted criticism from the Dutch association of 
dermatologists.
In general, several types of skin cancer applications can 
provide useful information for users. However, it seems that 
more research is needed to allow for applications that provide 
enough sensitivity and specificity for routine medical use and 
self-screening. Each application that is used for such purposes 
should be independently assessed using an adequate study 
design before by being utilised. By making these results public, 
they can be assessed by the different stakeholders.
Confilct of interest: none declared
Jelle Stans
Institute for Globally Distributed Open Research and Education
Beringen, Belgium
e-mail: jelle.stans@igdore.org 
Received: 9 Sep 2020 
Accepted: 17 Sep 2020
References
1. Charbonneau D, Hightower S, Katz A, et al. Smartphone apps for cancer: 
A content analysis of the digital health marketplace. Digit Health. 2020; 
6: 205520762090541, doi: 10.1177/2055207620905413.
2. Chao E, Meenan C, Ferris L. Smartphone-Based Applications for Skin 
Monitoring and Melanoma Detection. Dermatol Clin. 2017; 35(4): 
551–557, doi: 10.1016/j.det.2017.06.014.
277
3. Chuchu N, Takwoingi Y, Dinnes J, et al. Smartphone applications for 
triaging adults with skin lesions that are suspicious for melanoma. 
Cochrane Database Syst Rev. 2018, doi: 10.1002/14651858.cd013192.
4. Freeman K, Dinnes J, Chuchu N, et al. Algorithm based smartphone apps 
to assess risk of skin cancer in adults: systematic review of diagnostic 
accuracy studies. BMJ. 2020: m127, doi: 10.1136/bmj.m127.
5. Rat C, Hild S, Sérandour JR, et al. Use of Smartphones for Early Detection 
of Melanoma: Systematic Review. J Med Internet Res. 2018; 20(4): e135, 
doi: 10.2196/jmir.9392.
